Salvatore Privitera serves as the Chief Technical Officer at AtriCure, Inc., a leading innovator in surgical treatments for atrial fibrillation and left atrial appendage management. With a robust background in biomedical engineering and medical device development, Privitera has been instrumental in driving AtriCure’s technological advancements and product innovations. He holds a Ph.D. in Biomedical Engineering from the University of Wisconsin-Madison, where his research focused on developing novel medical devices and improving patient outcomes through technology. Throughout his career, Privitera has held various leadership roles in the medical device industry, contributing significantly to the development and commercialization of cutting-edge technologies. His work has been recognized with numerous patents and publications, reflecting his commitment to advancing the field of cardiac surgery. At AtriCure, Privitera leads a team of engineers and scientists dedicated to developing innovative solutions that improve the treatment of atrial fibrillation and reduce the risk of stroke. His strategic vision and technical expertise have been pivotal in positioning AtriCure as a leader in the cardiac ablation market. In his role as Chief Technical Officer, Privitera is responsible for overseeing the company’s research and development efforts, ensuring that AtriCure remains at the forefront of medical innovation. He collaborates closely with clinical teams to translate scientific discoveries into practical, patient-centered solutions. Under his leadership, AtriCure has successfully launched several groundbreaking products, enhancing the company’s portfolio and reinforcing its commitment to improving patient care. Privitera’s leadership and dedication to excellence continue to drive AtriCure’s mission to innovate and provide life-changing treatments for patients worldwide.